Prognostic Factors for Thymic Epithelial Neoplasms, with Emphasis on Tumor Staging

Hematology/Oncology Clinics of North America

Volumn 22, Issue 3, 2008, Pages 527-542

  Wick, Mark R ^a  

^a UNIVERSITY OF VIRGINIA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INVASION; CANCER STAGING; CLINICAL PRACTICE; EPITHELIUM CELL; HISTOPATHOLOGY; HUMAN; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; THYMOMA; THYMUS CANCER;

HUMANS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; THYMOMA; THYMUS NEOPLASMS;

EID: 44349089260     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2008.03.008     Document Type: Review

References (101)

1. Binkley F.M., Thorburn J.D., Stephens H.B., et al. Mediastinal tumors of thymic origin. Calif Med 78 (1953) 267-273
2. Soutter L., Sommers S., Relman A.S., et al. Problems in the surgical management of thymic tumors. Ann Surg 146 (1957) 424-437
3. Sellors T.H., Thackray A.C., and Thomson A.D. Tumors of the thymus. Thorax 22 (1967) 193-221
4. Lowenhaupt E. Tumors of the thymus in relation to the thymic epithelial anlage. Cancer 1 (1948) 547-563
5. Rosai J., and Levine G.D. Thymic hyperplasia and neoplasia: a review of current concepts. Hum Pathol 9 (1978) 495-515
6. Lewis J.E., Wick M.R., Scheithauer B.W., et al. Thymomas: a clinicopathologic review. Cancer 60 (1987) 2727-2743
7. Dotto J., Pelosi G., and Rosai J. Expression of p63 in thymomas and normal thymus. Am J Clin Pathol 127 (2007) 415-420
8. Pan C.C., Chen P.C., Chou T.Y., et al. Expression of calretinin and other mesothelioma-related markers in thymic carcinomas and thymoma. Hum Pathol 34 (2003) 1155-1162
9. Chan J.K.C., Tsang W.Y., Sereviratne S., et al. The MIC2 antibody 013: practical application for the study of thymic epithelial tumors. Am J Surg Pathol 19 (1995) 1115-1123
10. Kuo T.T., and Chan J.K.C. Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile. Am J Surg Pathol 22 (1998) 1474-1481
11. Dorfman D.M., Shahsafaei A., and Chan J.K.C. Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5-immunoreactivity. Am J Surg Pathol 21 (1997) 936-940
12. Woda B.A., Bain K., and Vander Salm T. The phenotype of lymphocytes in thymoma as studied with monoclonal antibodies. Clin Immunol Immunopathol 30 (1984) 197-201
13. Ritter J.H., and Wick M.R. Primary carcinomas of the thymus gland. Semin Diagn Pathol 16 (1999) 18-31
14. Suster S., and Moran C.A. Thymic carcinoma: spectrum of differentiation and histologic types. Pathology 30 (1998) 111-122
15. Riedel R.F., and Burfeind Jr. W.R. Thymoma: benign appearance, malignant potential. Oncologist 11 (2006) 887-894
16. Lara Jr. P.N. Malignant thymoma: current status and future directions. Cancer Treat Rev 26 (2000) 127-131
17. Wilkins E.W., Edmunds Jr. L.H., and Castleman B. Cases of thymoma at the Massachusetts General Hospital. J Thorac Cardiovasc Surg 52 (1966) 322-330
18. Fechner R.E. Recurrence of noninvasive thymomas: report of four cases and review of literature. Cancer 23 (1969) 1423-1427
19. LeGolvan D.P., and Abell M.R. Thymomas. Cancer 39 (1977) 2142-2157
20. Bernatz P.E., Khonsari S., Harrison Jr. E.G., et al. Thymoma: factors influencing prognosis. Surg Clin North Am 53 (1973) 885-892
21. Cowen D., Hannoun-Levi J.-M., Rosbeut M., et al. Natural history and treatment of malignant thymoma. Oncology 12 (1998) 1001-1005
22. Pollack A., Komaki R., Cox J.D., et al. Thymoma: treatment and prognosis. Int J Radiat Oncol Biol Phys 23 (1992) 1037-1043
23. Verley J.M., and Hollmann K.H. Thymoma: a comparative study of clinical stages, histologic features, and survival in 200 cases. Cancer 55 (1985) 1074-1086
24. Monden Y., Nakahara K., Iioka S., et al. Recurrence of thymoma: clinicopathological features, therapy, and prognosis. Ann Thorac Surg 39 (1985) 165-169
25. Maggi G., Giaccone G., Donadio M., et al. Thymomas: a review of 169 cases with particular reference to results of surgical treatment. Cancer 58 (1986) 765-776
26. Ribet C., Voisin C., Gosselin B., et al. Les thymomes lympho-epitheliaux: Etude anatomo-clinique et therapeutique de 113 cas. Rev Mal Respir 5 (1988) 53-60
27. Park M.S., Chung K.Y., Kim K.D., et al. Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification. Ann Thorac Surg 78 (2004) 992-998
28. Rea F., Marulli G., Girardi R., et al. Long-term survival and prognostic factors in thymic epithelial tumors. Eur J Cardiothorac Surg 26 (2004) 412-418
29. Kondo K., and Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 76 (2003) 878-884
30. Nakagawa K., Asamura H., Matsuno Y., et al. Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg 126 (2003) 1134-1140
31. Rios A., Torres J., Galindo P.J., et al. Prognostic factors in thymic epithelial neoplasms. Eur J Cardiothorac Surg 21 (2002) 307-313
32. Lardinois D., Rechsteiner R., Lang R.H., et al. Prognostic relevance of Masaoka and Muller-Hermelink classification in patients with thymic tumors. Ann Thorac Surg 69 (2000) 1550-1555
33. Gripp S., Hilgers K., Wurm R., et al. Thymoma: prognostic factors and treatment outcomes. Cancer 83 (1998) 1495-1503
34. Kesler K.A., Wright C.D., and Loehrer Sr. P.J. Thymoma: current medical and surgical management. Semin Neurol 24 (2004) 63-73
35. Salyer W.R., and Eggleston J.C. Thymoma: a clinical and pathological study of 65 cases. Cancer 37 (1976) 229-249
36. Regnard J.F., Magdeleinat P., Dromer C., et al. Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg 112 (1996) 376-381
37. Wilkins Jr. E.W., Grillo H.C., Scannell J.G., et al. Role of staging in prognosis and management of thymoma. Ann Thorac Surg 51 (1991) 888-892
38. de Perrot M., Liu J., Bril V., et al. Prognostic significance of thymomas in patients with myasthenia gravis. Ann Thorac Surg 74 (2002) 1658-1662
39. Sonobe M., Nakagawa M., Ichinose M., et al. Thymoma: analysis of prognostic factors. Jpn J Thorac Cardiovasc Surg 49 (2001) 35-41
40. Morgenthaler T.I., Brown L.R., Colby T.V., et al. Thymoma. Mayo Clin Proc 68 (1993) 1110-1123
41. Souadjian J.V., Enriquez P., Silverstein M.N., et al. The spectrum of diseases associated with thymoma: coincidence or syndrome?. Arch Intern Med 134 (1974) 374-379
42. Bernatz P.E., Harrison Jr. E.G., and Clagett O.T. Thymoma: a clinicopathologic study. J Thorac Cardiovasc Surg 42 (1961) 424-444
43. Marino M., and Muller-Hermelink H.K. Thymoma and thymic carcinoma: relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch A Pathol Anat Histopathol 407 (1985) 119-149
44. Muller-Hermelink H.K., Marino M., and Palestro G. Pathology of thymic epithelial tumors. Curr Top Pathol 75 (1986) 207-268
45. Kornstein M.J. Controversies regarding the pathology of thymomas. Pathol Annu 27 Part 2 (1992) 1-15
46. Pescarmona E., Rendina E.A., Venuta F., et al. Analysis of prognostic factors and clinicopathological staging of thymoma. Ann Thorac Surg 50 (1990) 534-538
47. Lequaglie C., Giudice G., Brega-Massone P.P., et al. Clinical and pathologic predictors of survival in patients with thymic tumors. J Cardiovasc Surg 43 (2002) 269-274
48. Kirchner T., Schalke B., Buchwald J., et al. Well-differentiated thymic carcinoma: an organotypical low-grade carcinoma with relationship to cortical thymoma. Am J Surg Pathol 16 (1992) 1153-1169
49. Pan C.C., Chen W.Y., and Chiang H. Spindle-cell and mixed spindle-cell/lymphocytic thymomas: an integrated clinicopathologic and immunohistochemical study of 81 cases. Am J Surg Pathol 25 (2001) 111-120
50. Kuo T.T., and Lo S.K. Thymoma: a study of the pathologic classification of 71 cases with evaluation of the Muller-Hermelink system. Hum Pathol 24 (1993) 766-771
51. Pescarmona E., Rendina E.A., Venuta F., et al. The prognostic implication of thymoma histologic subtyping: a study of 80 consecutive cases. Am J Clin Pathol 93 (1990) 190-195
52. Quintanilla-Martinez L., Wilkins Jr. E.W., Ferry J.A., et al. Thymoma-morphologic subclassification correlates with invasiveness and immunohistologic features: a study of 122 cases. Hum Pathol 24 (1993) 958-969
53. Shimosata Y., and Mukai K. Tumors of the mediastinum. In: Rosai J. (Ed). Atlas of tumor pathology, Series 3. Fascicle 21 (1997), Armed Forces Institute of Pathology, Washington, DC 33-273
54. Dawson A., Ibrahim N.B., and Gibbs A.R. Observer variation in the histopathological classification of thymomas: correlation with prognosis. J Clin Pathol 47 (1994) 519-523
55. Moran C.A., and Suster S. On the histologic heterogeneity of thymic epithelial neoplasms: impact of sampling in subtyping and classification of thymomas. Am J Clin Pathol 114 (2000) 760-766
56. Rosai J. Histological typing of tumors of the thymus by the World Health Organization. 2nd edition (1999), Springer-Verlag, Berlin p. 9-15
57. Chen G., Marx A., Wen-Hu C., et al. New WHO classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer 95 (2002) 420-429
58. Okumura M., Ohta M., Miyoshi S., et al. Oncological significance of WHO histological thymoma classification: a clinical study based on 286 patients. Jpn J Thorac Cardiovasc Surg 50 (2002) 189-194
59. Okumura M., Ohta M., Tateyama H., et al. The World Health Organization histologic classification System reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 94 (2002) 624-632
60. Okumura M., Miyoshi S., Fujii Y., et al. Clinical and functional significance of WHO classification on human thymic epithelial neoplasms: a study of 146 consecutive tumors. Am J Surg Pathol 25 (2001) 103-110
61. Dadmanesh F., Sekihara T., and Rosai J. Histologic typing of thymoma according to the new World Health Organization classification. Chest Surg Clin N Am 11 (2001) 407-420
62. Suster S., and Moran C.A. Thymoma, atypical thymoma, and thymic carcinoma: a novel conceptual approach to the classification of thymic epithelial neoplasms. Am J Clin Pathol 111 (1999) 826-833
63. Suster S., and Moran C.A. Primary thymic epithelial neoplasms: spectrum of differentiation and histological features. Semin Diagn Pathol 16 (1999) 2-17
64. Wick M.R. Assessing the prognosis of thymomas. Ann Thorac Surg 50 (1990) 521-522
65. Bergh N.P., Gatzinsky P., Larsson S., et al. Tumors of the thymus and thymic region. I. Clinicopathological studies on thymomas. Ann Thorac Surg 25 (1978) 91-98
66. Wilkins E.W., and Castleman B. Thymoma: a continuing survey at the Massachusetts General Hospital. Ann Thorac Surg 28 (1979) 252-256
67. Masaoka A., Monden Y., Nakahara K., et al. Follow-up study of thymomas with special reference to their clinical stages. Cancer 48 (1981) 2485-2492
68. Stremmel C., Dango S., Thiemann U., et al. [Thymoma-incidence, classification, and therapy]. Dtsch Med Wochenschr 132 (2007) 2090-2095 [in German]
69. Shin D.M., Walsh G.L., Komake R., et al. A multidisciplinary approach to therapy for unresectable malignant thymoma. Ann Intern Med 129 (1998) 100-104
70. Blumberg D., Port J.L., Weksler B., et al. Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg 60 (1995) 908-913
71. Mehran R., Ghosh R., Maziak D., et al. Surgical treatment of thymoma. Can J Surg 45 (2002) 25-30
72. Singhal S., Shrager J.B., Rosenthal D.I., et al. Comparison of stages I and II thymoma treated by complete resection with or without adjuvant radiation. Ann Thorac Surg 76 (2003) 1635-1642
73. Rena O., Papalia E., Oliaro A., et al. Does adjuvant radiation therapy improve disease-free survival in completely resected Masaoka stage II thymoma?. Eur J Cardiothorac Surg 31 (2007) 109-113
74. Mangi A.A., Wright C.D., Allan J.S., et al. Adjuvant radiation therapy for stage II thymoma. Ann Thorac Surg 74 (2002) 1033-1037
75. Ogawa K., Uno T., Toita T., et al. Postoperative radiotherapy for patients with completely-resected thymoma: a multi-institutional, retrospective review of 103 patients. Cancer 94 (2002) 1405-1413
76. Marchevsky A.M., Gupta R., McKenna R.J., et al. Evidence-based pathology and the pathologic evaluation of thymomas: there is no difference in disease-free and overall survival in patients with stages I and II thymoma. Arch Pathol Lab Med (2008) in press
77. Wright C.D. Pleuropneumonectomy for the treatment of Masaoka stage IVa thymoma. Ann Thorac Surg 82 (2006) 1234-1239
78. Haniuda M., Kondo R., Numanami H., et al. Recurrence of thymoma: clinicopathological features, reoperation, and outcome. J Surg Oncol 78 (2001) 183-188
79. Luebke T., Beckurts K.T., Wickenhauser C., et al. Masaoka staging is of prognostic relevance in type B3/C thymomas. Anticancer Res 24 (2004) 4113-4119
80. Blumberg D., Burt M.E., Bains M.S., et al. Thymic carcinoma: current staging does not predict prognosis. J Thorac Cardiovasc Surg 115 (1998) 303-308
81. Gamondes J.P., Balawi A., Greenland T., et al. Seventeen years of surgical treatment of thymoma: factors influencing survival. Eur J Cardiothorac Surg 5 (1991) 124-131
82. Cowen D., Richaud P., Mornex F., et al. Thymoma: results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of the literature. FNCLCC trialists, Federation Nationale des Centres de Lutte Contre le Cancer. Radiother Oncol 34 (1995) 9-16
83. Yamakawa Y., Masaoka A., Hashimoto T., et al. A tentative tumor-node-metastasis classification of thymoma. Cancer 68 (1991) 1984-1987
84. Tsuchiya R., Koga K., Matsuno Y., et al. Thymic carcinoma: proposal for pathological TNM staging. Pathol Int 44 (1994) 505-512
85. Asamura H., Nakagawa K., Matsuno Y., et al. Thymoma needs a new staging system. Interact Cardiovasc Thorac Surg 3 (2004) 163-167
86. Stremmel C., and Passlick B. [Surgery of mediastinal tumors]. Chirurg 79 (2008) 9-17 [in German]
87. Wright C.D., and Kessler K.A. Surgical treatment of thymic tumors. Semin Thorac Cardiovasc Surg 17 (2005) 20-26
88. Lin C.S., Kuo T.T., Hsu W.H., et al. Management of locally-advanced unresectable thymic epithelial tumors. J Chin Med Assoc 67 (2004) 172-178
89. Sugiura H., Morikawa T., Ito K., et al. Long-term results of surgical treatment for invasive thymoma. Anticancer Res 19 (1999) 1433-1437
90. Wakely P.E. Cytopathology-histopathology of the mediastinum: epithelial, lymphoproliferative, and germ-cell neoplasms. Ann Diagn Pathol 6 (2002) 30-43
91. Wick M.R., and Powers C.N. The thymus and mediastinum. In: Silverberg S.G. (Ed). Silverberg's principles & practice of surgical pathology & cytopathology. 4th edition (2006), Churchill-Livingstone-Elsevier, New York 1091-1134
92. Jeong Y.J., Lee K.S., Kim J., et al. Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis?. Am J Roentgenol 183 (2004) 283-289
93. Sadohara J., Fujimoto K., Muller N.L., et al. Thymic epithelial tumors: comparison of CT and MR imaging findings of low-risk thymomas, high-risk thymomas, and thymic carcinomas. Eur J Radiol 60 (2006) 70-79
94. Inaoka T., Takahashi K., Mineta M., et al. Thymic hyperplasia and thymus gland tumors: differentiation with chemical-shift MR imaging. Radiology 243 (2007) 869-876
95. Suster S., and Moran C.A. Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma: a clinicopathologic study of 22 cases. Am J Surg Pathol 20 (1996) 1469-1480
96. Maruyama R., Suemitsu R., Okamoto T., et al. Persistent and aggressive treatment for thymic carcinomas: results of a single-institute experience with 25 patients. Oncology 70 (2006) 325-329
97. Lin J.T., Wei-Shu W., Yen C.C., et al. Stage IV thymic carcinoma: a study of 20 patients. Am J Med Sci 330 (2005) 172-175
98. Kurup A., and Loehrer Sr. P.J. Thymoma and thymic carcinoma: therapeutic approaches. Clin Lung Cancer 6 (2004) 28-32
99. Takeda S., Sawabata N., Inoue M., et al. Thymic carcinoma: clinical institutional experience with 15 patients. Eur J Cardiothorac Surg 26 (2004) 401-406
100. Eng T.Y., Fuller C.D., Jagirdar J., et al. Thymic carcinoma: state of the art review. Int J Radiat Oncol Biol Phys 59 (2004) 654-664
101. Suster S., and Rosai J. Thymic carcinoma: a clinicopathologic study of 60 cases. Cancer 15 (1991) 1025-1032